Subscribe
www-billionphotos-com-shutterstock-com-11
www.BillionPhotos.com / Shutterstock.com
29 February 2016Americas

Polymer patent invalidated by split Federal Circuit

The US Court of Appeals for the Federal Circuit has invalidated a polymer patent owned by Howmedica Osteonics, reversing an earlier decision from the US Patent and Trademark Office (USPTO) and ending the company’s long running dispute with medical device company Zimmer.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Federal Circuit upholds Howmedica patent ruling
13 May 2016   The US Court of Appeals for the Federal Circuit has refused to review an earlier ruling that invalidated a patent owned by Howmedica Osteonics in the company’s dispute with medical device company Zimmer.


Editor's picks

‘We created law’: G1/24 and the creation of the ‘diamond standard’
Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

Editor's picks

Europe
‘We created law’: G1/24 and the creation of the ‘diamond standard’
3 July 2025

More on this story

Americas
Federal Circuit upholds Howmedica patent ruling
13 May 2016   The US Court of Appeals for the Federal Circuit has refused to review an earlier ruling that invalidated a patent owned by Howmedica Osteonics in the company’s dispute with medical device company Zimmer.

More on this story

Americas
Federal Circuit upholds Howmedica patent ruling
13 May 2016   The US Court of Appeals for the Federal Circuit has refused to review an earlier ruling that invalidated a patent owned by Howmedica Osteonics in the company’s dispute with medical device company Zimmer.

More features

‘We created law’: G1/24 and the creation of the ‘diamond standard’
BMS unit loses cell therapy patent at European Patent Office
Amgen sues Biocon over blockbuster bone drugs as first biosimilars enter market
Lord Justice Birss to become chancellor of the High Court
Bankruptcy judge approves $305m sale of genetics testing company
Sanofi successfully challenges rare disease patent in Europe
Bayer appoints new head of IP
WATCH: Policy direction—where are we now?